Conservative management of isolated splenic abscess in children

J Pediatr Surg. 2010 Feb;45(2):372-5. doi: 10.1016/j.jpedsurg.2009.10.074.

Abstract

Introduction: Isolated splenic abscesses (SAs) are rare in children. We report a single-center experience with emphasis on their diagnosis, etiology, treatment, and outcome.

Methods: This is a retrospective review.

Results: Eighteen children (age, 3-16 years; male-female ratio, 5:1) were managed over a period of 8 years in a tertiary-care institution. Presenting symptoms included fever, abdominal pain, and anorexia. Splenomegaly was present in 12 (67%), leukocytosis in 9 (50%), and thrombocytosis in 12 (67%) patients. Associated diseases were thalassemia (1), tuberculosis (1), and typhoid fever (9). Solitary and multiple SAs were seen in equal numbers. Blood culture grew Salmonella paratyphi A in 1 case. Splenic aspirate culture was positive in 3 (Escherichia coli [1], S paratyphi A [1], Acinetobacter [1]). Widal serology was positive in 9 (50%) patients. Management consisted of intravenous broad-spectrum antibiotic therapy in all patients, together with percutaneous aspiration in 10 (56%) cases where the abscess size was greater than 3 cm. All patients responded, and complete resolution was observed.

Conclusion: Isolated SA in children responds favorably to conservative treatment with intravenous broad-spectrum antibiotics and percutaneous drainage without the need for splenectomy.

Publication types

  • Comparative Study

MeSH terms

  • Abscess / drug therapy
  • Abscess / surgery
  • Abscess / therapy*
  • Adolescent
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Drainage / methods*
  • Enterobacteriaceae Infections / therapy
  • Escherichia coli Infections / therapy
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Retrospective Studies
  • Splenic Diseases / drug therapy
  • Splenic Diseases / surgery
  • Splenic Diseases / therapy*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents